Senior Manager, SEC Reporting
Remix Therapeutics
| Company | Remix Therapeutics |
| Category | Finance |
| Location | Watertown |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Senior |
| Salary | Not stated by the employer |
| Posted | 8 Jun 2026 |
| Last verified | 2 Aug 2026 |
| Source | Employer career page (greenhouse) |
Description
Remix launched with a vision to transform patients’ lives through modulation of RNA processing. Our breakthrough science enables the identification of small molecules that influence the expression of disease ‑ driving mRNAs and proteins. We focus on diseases of high unmet medical need and are committed to operating with scientific rigor and urgency. With a proprietary in ‑ house technology platform, we have rapidly generated multiple discovery programs advancing toward the clinic. Remix Therapeutics was recognized as one of BioSpace’s Best Places to Work in Boston 2025 and is backed by leading life sciences investors.
Position Summary:
The Senior Manager, SEC Reporting will play a critical role in supporting public company readiness initiatives and leading external financial reporting activities. Reporting to the Head of Finance, this individual will be responsible for preparing SEC filings, supporting technical accounting matters, and helping establish scalable reporting and compliance processes appropriate for a public company environment. The ideal candidate will bring strong technical accounting expertise, excellent project management capabilities, and the ability to work independently in a fast-paced clinical-stage biotech environment.
This is an exciting opportunity to join a growing clinical-stage biotechnology company at a transformational stage and help build the infrastructure of a future public company. The role offers meaningful exposure to executive leadership, opportunities for professional growth, and the ability to make a significant impact on the organization’s future success.
Key Responsibilities:
Prepare and coordinate SEC filings, including Forms S-1, 10-Q, 10-K, 8-K, and related disclosures and supporting schedules
Draft and review footnote disclosures and MD&A in accordance with U.S. GAAP and SEC reporting requirements
Support IPO readiness activities, including implementation of disclosure controls and SOX compliance processes
Partner cross-functionally with FP&A, Legal, HR, Clinical Operations, and external auditors/advisors to gather and validate information for filings
Research technical accounting matters and prepare accounting memoranda
Coordinate reporting timelines and ensure timely and accurate filings
Support quarterly and annual close activities related to external reporting
Assist with equity accounting and stock compensation reporting
Monitor new accounting pronouncements and SEC regulations and assess their impact on the company
Drive process improvements and help build scalable reporting infrastructure as the organization grows
Personal Attributes:
Highly detail-oriented with strong analytical and problem-solving skills
Hands-on, proactive, and solutions-oriented mindset
Comfortable operating in a dynamic, fast-paced environment
Collaborative team player with strong interpersonal skills
Ability to maintain confidentiality and exercise sound judgment
Qualifications:
Required
Bachelor's degree in accounting or finance
Active CPA license required
Minimum 5+ years of progressive accounting and financial reporting experience
Big 4 public accounting experience
Clinical-stage biotechnology or life sciences industry experience
Strong understanding of U.S. GAAP and SEC reporting requirements
Strong written
You found the opening. Now track it.Tracker, radar and AI drafts in one place.erioun.com →